Celiac Disease on a Gluten-Free Diet – Takeda – IQVIA PRIME

People with Active Celiac Disease are asked to participate in a research study being conducted by NYU Grossman School of Medicine.

You may be eligible to participate in this study if you:

• Have at least 1 CeD-related GI symptom of moderate or greater severity
• Have biopsy-confirmed CeD
• Have been attempting to maintain a GFD for at least 12 months
• Have small intestinal villous atrophy on duodenal biopsy
• Have a body mass index (BMI) between 16 and 35

You may NOT participate in this study if you:

• Are an immediate family member, study site employee, or is in a dependent relationship with a study site employee who is involved in conduct of this study
• Have inadequate renal or hepatic function
• Have the presence of other inflammatory GI disorders or systemic autoimmune Diseases
• Have had ongoing systemic immunosuppressant, systemic corticosteroid treatment, or Treatment
• Have a known or suspected severe enteric infection (viral, bacterial, or parasitic) within 6 months
• Have known or suspected coronavirus disease 2019 (COVID-19)
• Have known immunodeficiency virus (HIV) infection. Hepatitis B, or C
• Are pregnant or breastfeeding

Contact Information
Ghoncheh Ghiasian, Study Coordinator
Phone: (212) 263-5290